Aug 2026· Stem Cell Reports· Vol 21, pp. 103047· 0 citations· 33 references
Medicine
TL;DR
Stem cell core facilities support both fundamental and translational research, promote rigor and reproducibility, and foster collaboration, while driving the establishment of stem cell core facilities.
Abstract
Summary Over the past three decades, advances in human pluripotent stem cell (hPSC) technologies, including induced pluripotent stem cells, gene editing, and 2D/3D models, have transformed biomedical research. These powerful tools have revolutionized disease modeling, drug discovery, and the development of advanced therapy medicinal products (ATMPs), while driving the establishment of stem cell core facilities. By providing specialized expertise, standardized workflows, and access to advanced technologies, these facilities support both fundamental and translational research, promote rigor and reproducibility, and foster collaboration. This manuscript highlights their role as hubs of excellence and discusses current challenges and future opportunities for the global stem cell community.
This Review evaluates the technological and translational trajectories that have defined the iPSC era and analyzes the operational barriers to therapeutic development, envisioning a paradigm shift in which iPSC-derived interventions transition from bespoke experimental models toward standardized, engineered biological...
Jaecheol Lee, Todd J. Herron, L. Studer et al.· Nature Medicine· 0 citations
Despite major advances in cancer genomics and immunotherapy, the field remains limited by experimental models that fail to faithfully recapitulate human tumor initiation, genetic context, and immune-tumor interactions. Traditional animal and immortalized cell models often lack predictive power for therapeutic response...
Chih-Wei Chu, Yen-Tzu Chang, Candise Tat et al.· Trends in Molecular Medicine· 0 citations
This review traces key field milestones and analyzes prospects and hurdles for next-generation iPSC therapies as autologous and allogeneic iPSC therapies complement each other for distinct clinical demands.
Anmin Wang, Yunpei Zhang, Hong-Kui Deng et al.· Cell Reports Medicine· 0 citations
The article traces the trend of directed differentiation technologies evolving from two-dimensional culture to three-dimensional organoids and details their practical applications in diseases such as stroke, Alzheimer's disease, and spinal cord injury—particularly in spinal cord injury models, where transplanted cells...
Dai-Yi Yang· International Journal of Bio...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.